Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 235 (8%)
Anticipated shortage: 19 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 100MG TABLET Resolved 2021-05-14 2021-05-31 139416
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-14 2021-06-14 139413
EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES 400MG CAPSULE Actual shortage 2021-05-14 2022-03-17 139409
APO-CANDESARTAN 16MG TABLET Resolved 2021-05-14 2021-07-30 139406
APO-BACLOFEN 20MG TABLET Resolved 2021-05-14 2021-08-03 139403
APO-AMLODIPINE-ATORVASTATIN 40MG 10MG TABLET Resolved 2021-05-14 2021-05-26 139400
APO-AMBRISENTAN 10MG TABLET Resolved 2021-05-14 2021-06-14 139397
APO-AMBRISENTAN 5MG TABLET Resolved 2021-05-14 2021-06-14 139394
APO-VARENICLINE 1MG TABLET Actual shortage 2021-05-07 2022-02-03 138992
APO-TRAZODONE TABLETS 50MG 50MG TABLET Resolved 2021-05-07 2021-05-17 138984
APO-TADALAFIL 5MG TABLET Resolved 2021-05-07 2021-06-14 138978
APO-RAMIPRIL 1.25MG CAPSULE Resolved 2021-05-07 2021-06-07 138971
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2021-05-07 2021-06-14 138966
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-07 2021-07-02 138963
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-07 2021-09-20 138960
APO-LAMIVUDINE HBV 100MG TABLET Resolved 2021-05-07 2021-06-28 138957
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2021-05-07 2021-05-26 138954
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2021-05-07 2021-05-26 138951
APO-ROSUVASTATIN 40MG TABLET Resolved 2021-04-30 2021-05-25 138355
APO-QUETIAPINE 25MG TABLET Resolved 2021-04-30 2021-05-31 138352

Showing 1221 to 1240 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TELMISARTAN 40MG TABLET Discontinued 2019-01-04 2019-01-04 71345
APO-BOSENTAN 125.0MG TABLET Discontinued 2019-01-04 2019-01-04 71342
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
NAPROXEN SODIUM TABLETS 220MG TABLET Discontinued 2019-01-04 2019-01-04 71228
ACETAMINOPHEN CAPLETS 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71225
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71222
ACETAMINOPHEN TABLETS USP 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71219
ACETAMINOPHEN TABLETS USP 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71216
APO-LOSARTAN 100MG TABLET Discontinued 2019-01-04 2019-01-04 71213
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
ACID CONTROL Discontinued 2019-01-04 2019-01-04 71198
APO-CEFPROZIL 250MG TABLET Discontinued 2019-01-04 2019-02-21 71195
ACETAMINOPHEN HEADACHE ULTRA RELIEF 500MG 65MG TABLET Discontinued 2019-01-04 2019-01-04 71192

Showing 61 to 80 of 356